Introduction Solitary fibrous tumors (SFTs) are uncommon mesenchymal neoplasms and are particularly rare in the female genital tract. Doege-Potter syndrome is a paraneoplastic syndrome involving SFT-associated hypoglycemia. We report, for the first time, on a broad ligament SFT with Doege-Potter syndrome; additionally, we review 30 cases of women with SFTs reported in the literature.
Introduction
Solitary fibrous tumors (SFTs) are an uncommon mesenchymal neoplasm with an incidence rate of 2.8 per 100,000. [1, 2] Paraneoplastic syndrome of hypoglycemia (Doege-Potter syndrome) is observed in 5% to 10 .4% of all patients. [3] While this tumor type can be found in any organ, its occurrence in the female genital tract is extremely rare. There were more than 2000 cases of SFTs reported in the English-language literature; approximately 80 of these cases involved hypoglycemia, and 30 originated in the female genital tract. We here reported for the first time a broad ligament SFT with Doege-Potter syndrome.
Case report
A previously healthy 37-year-old woman presented at our institution with an enormous pelvic mass and severe hypoglycemia. Beforehand, she had visited the Department of Sleep and Endocrinology complaining of occasional drowsiness and confusion for 1 month. She had never complained of any symptoms related to the gynecologic or gastrointestinal organs.
Laboratory data revealed persistent hypoglycemia (glucose 0.61-2.97 mmol/L [normal, 3.90-6.10]), insulin 0.20 mU/mL [normal, 1.50-15] , C-peptide < 0.01 nmol/L [normal, 0.48-0.78], and insulin-related growth factor-1 36 ng/mL [normal, 94-358] ). Test results ruled out a functional islet cell tumor, thyroid dysfunction, or adrenal dysfunction. Computed tomography (CT) of the pelvis showed that the right iliac vessels were pressed against the congruous pelvic wall by an enormous pelvic mass, and intravenous blood flowed from the mass towards the womb (Fig. 1A, 1B) . Meanwhile, CT scans of the brain, thorax, and stomach were normal. A mass as large as a 16-week "pregnant uterus" with no tenderness was found through bimanual examination on the right pelvis, and the patient's actual uterus was pushed to the left. A presumptive diagnosis of a broad ligament leiomyoma was made.
A massive lesion covered by dense thumb-wide vasculum within the right broad ligament was observed under exploratory laparotomy, which was consistent with CT data. Tumor resection, sub-extensive hysterectomy, bilateral salpingo-oophorectomy, and pelvic lymphadenectomy were subsequently performed by the most experienced group at our institution since the tumor appeared to be a poorly differentiated endometrial stromal sarcoma (ESS) on frozen sectioning. The surgery lasted 400 min, and the volume of blood loss was 5000
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The authors have no conflicts of interest to disclose. mL in total while that of the mass resection was 4900 mL; 12 units of packed red cells and 1000 mL of plasma were administered. Serum glucose levels soared to 17.10 mmol/L as soon as the tumor was resected. The patient subsequently recovered well and was discharged on day 5 post-surgery.
Macroscopically, the tumor measured 16 Â 15 Â 15 cm with clearly defined margins. It exhibited a rotten fish, meat-like, and jelly-like appearance and was grayish-white in color with multiple cystic components containing brown liquid. Microscopically, the atypical neoplastic tumor cells were in a poorly formed arrangement with approximately 14 mitotic figures per 10 highpower fields (Fig. 2A) ; branching vessels ( Fig. 2B ) and necrotic foci (Fig. 2C) were also observed. Immunohistochemically, the tumor was positive for CD34 (Fig. 2D) , CD99 (Fig. 2E) , vimentin, and CD10, and was negative for Bcl-2, smooth muscle actin, and S100. The uterus, adnexa, and lymph nodes were negative for tumor cells. These results strongly supported a diagnosis of malignant SFT of the broad ligament of the uterus and Doege-Potter syndrome with R0 resection.
Six cycles of adjuvant chemotherapy with azithromycin, decarbonize, and ifosfamide were administered. Owing to the complete surgical resection, radiotherapy was not administered to this patient. Transvaginal ultrasonography was performed every 3 months and radiography was performed every 6 months for follow-up.
Forty-three months after surgery, CT scanning revealed a recurred right pelvic mass that was fundamentally different from the first. This was an intraperitoneal mass (7 Â 6.5 Â 4 cm) with the right iliac vessels pushed to the left side; moreover, the peritoneum was separated from the pelvic cavity by the tumor (Fig. 3) . The tumor was excised with 80 mL of blood loss, and a recurrence of malignant SFT was confirmed.
Currently (67 months after the first surgery), the patient is alive and being followed; there have been no episodes of hypoglycemia and she has remained tumor-free 28 months after the second excision. (Table 1 .)
Discussion
We searched the PubMed database using the search terms "solitary fibrous tumor," "Doege-Potter syndrome," "pelvic," "uterus," "cervix," "fallopian tube," "ovary," "vagina," and Table 2 .
Clinical findings
The median age of female patients was 51 years (range, 14-78 years). The most common location was the vulva (11/30), followed by the vagina (6/30), uterine corpus (6/30), uterine cervix (4/30), fallopian tube (1/30), round ligament (1/30), and broad ligament (1/30). The maximum tumor diameter ranged from 1 to 23 cm (median, 6 cm).
The clinical presentations of SFTs vary according to the tumors' locations, sizes, and features. There are usually no symptoms (14/30), especially at an early stage. Therefore, they tend to be large when discovered, and may also be found incidentally during imaging tests performed for other reasons. Large tumors may be accompanied by symptoms of regional pain . [4, 5] The paraneoplastic syndromes seborrheic keratosis (the Leser-Trélat sign), acromegaly (Pierre-Marie-Bamberg), and hypoglycemia (Doege-Potter) can rarely occur as a secondary effect of the tumor. Among the 30 patients investigated, only 1 was admitted to the hospital because of hypoglycemia with uterine corpus SFT; to our knowledge, ours is the first reported case of broad ligament SFT presenting with Doege-Potter syndrome. [6] 
Clinical diagnosis
Laboratory findings of SFTs are always unremarkable. In previous reports, 5 patients were described as having undergone B ultrasonography examination, 7 underwent CT, and 2 underwent magnetic resonance imaging (MRI), 1 underwent both CT and MRI; imaging studies were not mentioned for 15 patients. However, imaging examination alone is insufficient for differential diagnosis, as it lacks the ability to detect certain features typical of SFTs. CT scanning and MRI show tumors with a clear boundary and heterogeneous density that push against surrounding organs, but never with invasion. On the other hand, imaging is very effective for assessing the links between tumors and adjacent organs, and for determining whether a distant metastasis is present. Thus, once the diagnosis is established, the patient is recommended for re-evaluation with imaging to rule out a concurrent tumor, especially in the chest. [7, 8] Regular imaging examinations are also especially useful for follow-up examination.
Experienced pathologists are critical for the diagnosis of SFTs. Core needle biopsy of the superficial tumor is necessary for accurate disease diagnosis and prompt treatment; however, this has not been broadly applied in gynecological settings. Only 4 patients underwent fine-needle aspiration biopsy and were accurately diagnosed with SFTs preoperatively. A possible reason for the absence of fine-needle aspiration biopsy is that gynecologists do not consider this rare disease and instead assume uterine leiomyoma, ovarian cysts, cervical polyps, and even abscesses. Since the bulky lesion may have a rich blood supply (as was the case in our patient), the possibility of life-threatening hemorrhage ought to be considered. Additionally, the unpredictable biological behavior combined with the exceedingly rapid growth of these tumors may lead to needle-core biopsies and surgical specimens yielding discordant data. [9, 10] Grossly, the reported tumors ranged from 1 to 23 cm in maximum diameter (median: 6 cm) and generally comprised of firm lesions with well-demarcated margins and smooth surfaces. The cut face showed a mixture of solid and cystic components; some also exhibited mucinous areas. Microscopically, typical SFTs presented as both hypercellular and hypocellular lesions, with fibroblast-like cells in "patternless" patterns and "staghorn vascular cavity" formations. The definitive diagnosis required immunohistochemical analysis. In the 30 cases reviewed, all of the spindle cells (100%) expressed CD34; positivity for CD34 is reportedly a characteristic presentation observed in 90% to 95% of all SFTs. [11] Recently, Robinson et al [12] proposed a genetic diagnosis criterion, reporting that the NAB2-STAT6 fusion gene is specific to SFTs and can lead to STAT6 immunoexpression. Indeed, STAT6 is a biomarker with high sensitivity and specificity for distinguishing and diagnosing SFTs.
Diagnosing SFTs is a complex process; our patient serves as a reminder that, although extremely rare, Doege-Potter syndrome in the female reproductive organs should be quickly ruled out. If diagnosed, a multidisciplinary treatment effort is necessary. 
Clinical treatment
All 30 patients retrieved in our study were treated with en bloc excision; additionally, 9 (30%) underwent hysterectomy, and 4 (13.3%) underwent pelvic lymphadenectomy. As for adjuvant therapy, 3 women (10%) received radiation therapy and 1 (3.3%) received chemotherapy. Complete surgical resection with a clear margin is currently the most effective treatment modality, and surgery remains the best option for recurred tumors. [7, 13] Nevertheless, owing to these tumors' anatomical locations (e.g. the vagina, uterus, or cervix), adhesiveness and bulk present serious challenges to complete excision, therefore, the scope of surgery should be expanded appropriately to be manageable. Sidebotham et al [1] described a 14-year-old girl in whom a large cervical, deep SFT was discovered with a narrow vaginal anatomy; en bloc excision was performed with margins as close to negative as possible. To avoid metastasis or recurrence due to residual tumor tissue, trachelectomy, and pelvic sentinel lymphadenectomy were performed following the primary tumor excision.
Discriminating between benign and malignant SFTs is challenging, as their biological behaviors are difficult to predict. Hence, it is reasonable to treat all SFTs under the assumption that they are highly invasive. Mearini et al [14] reported a patient with a renal SFT that was difficult to diagnose definitively during the surgery; therefore, lymphadenectomy was performed after which lymph node metastases were discovered after the operation. A 64-year-old patient underwent mass resection, hysterectomy, bilateral salpingo-oophorectomy, and supplementary surgery involving inguinal lymph node dissection for malignant vulval SFT; however, she died of cancer metastasis. [15] In our patient described herein, we extended the scope of surgery owing to her tumor status and her own family's wishes; despite this, she experienced a recurrence.
In terms of surgical approaches, the use of holoscopic imaging during surgery is highly favored for pleural SFT lesions less than 5 cm to ensure R0 resection. [16] In the 30 patients researched in our study, most underwent some type of surgical approach, while only 2 underwent laparoscopic interventions to excise the fallopian tube SFT that was 6 cm in maximum diameter [17] and a cervical SFT lesion in the vagina combined with a metastatic lymph node, [1] respectively. Seven pelvic tumors were removed through laparotomy as their volumes were huge and their natures were unknown, thus necessitating a clean margin.
Furthermore, previous case studies strongly emphasize the importance of controlling intraoperative hemorrhaging instead of merely ensuring an adequate blood supply during surgery. In a patient with a 9.8 cm vulval SFT, 75 mL of blood was lost owing to a hysterectomy, while 500 mL was lost during tumor resection. [15] Noeakowski et al [2] described an operation for a cervical SFT (16 Â 10.9 Â 9.8 cm) that caused 2200 mL of blood loss. Other reports also described failed surgeries in which preoperative evaluation was not adequately performed because of massive bleeding. Pelvic SFTs usually have multiple feeder vessels and always arise from the internal iliac and inferior Table 2 The characteristics of patients with solitary fibrous tumor in female genital tract.
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Age (yr) Location Pathology Adjuvant Treatments Recurrence/Metastases Follow-up (months) [18] ( [2, 18] particularly in giant and deep pelvic tumors. Hence, the blood loss can be massive upon lesion resection, as was the case in our patient. Soda et al [19] described a pelvic tumor (16 Â 14 Â 9 cm) whose excision with the aid of an aortic balloon caused 13660 mL of blood loss. Another patient had a pre-rectal SFT (24 Â 13.2 Â 16 cm) that underwent embolization, causing the tumor to decrease in volume while central necrosis increased. [19] Taken together, preoperative observation, angiography, and embolization or insertion of an aortic balloon catheter should be considered to facilitate the surgery and avoid life-threatening bleeding while visualizing the surgical area as clearly as possible.
Because of the rarity of malignant SFTs and the good outcomes observed following complete surgical resection, there are no recommendations for adjuvant treatment. Although radiotherapy and chemotherapy were performed in our patient as well as another with a vulval SFT, both subsequently experienced recurrences. [15] 
Clinical prognosis
While most SFTs are benign, approximately 10% to 20% are malignant and display an aggressive phenotype with local recurrence or distant metastasis. [11, 13] Among the 30 patients found in the literature, 6 (20%) were diagnosed with malignant tumors; 2 had metastases to the lung and bone as well as local recurrence; 1 of whom was alive with disease and the other died 5 months after undergoing surgery and radiation therapy. Nine of the remaining 30 patients were lost to follow up, while the remaining 19 (including 4 of the patients with malignant tumors mentioned before) were alive without disease; the median followup time for these patients was 23.5 months (range, 5-132 months). It was previously suggested that SFT prognosis is dependent on the histological type; malignancy should be considered if 3 of the following 6 criteria are identified: parietal pleura location, dimensions ≥10 cm, hypercellularity, nuclear atypia, ≥4 mitoses/10 high-power fields, and/or necrosis. [10] Recently, other investigators also described older age (≥55 years), paraneoplastic syndrome, and incomplete tumor resection as indicators of poor outcome. [3, 11] Therefore, close long-term follow-up is recommended for achieving the best clinical outcomes; such follow-up should include abdominal ultrasonography and radiography of high-risk areas like the chest. Moreover, MRI or CT scans can be performed as necessitated by the clinical symptoms. [1] 
